Brain Cancer Archives - UNC Lineberger

September 3, 2022

News & Observer: Common lab molecule surprises researchers with potential cancer-fighting properties

Timothy R. Gershon, MD, PhD, is a UNC Lineberger member and an associate professor in the UNC School of Medicine Department of Neurology.

A study led by UNC Lineberger's Tim Gershon, MD, PhD, shows new evidence to explain how drug resistance develops in a major subtype of medulloblastoma.

UNC Lineberger's Timothy Gershon, MD, PhD, and Jennifer Ocasio, PhD, who identified a possible approach to blocking medulloblastoma brain tumor

UNC Lineberger researchers have identified a potential approach to stop the growth of medulloblastoma, the most common type of brain tumor in children.

UNC Lineberger's Charles M. Perou, PhD., is one of the presenters at the San Antonio Breast Cancer Symposium.

Before he set out to understand how tens of thousands of genes are behaving in breast cancer, Charles M. Perou, PhD, spent five years hunting one gene. That experience started his journey to becoming a world-renowned expert in genomics.

David Hesmer is a volunteer in a UNC Lineberger lab, helping to further the study of glioblastoma, something he knows a lot about: he was treated for glioblastoma at the N.C. Cancer Hospital.

UNC Lineberger's Shawn Hingtgen, PhD, and his colleagues published preclinical findings in PLoS ONE that demonstrate an innovative approach to treating edulloblastoma, the most common form of pediatric brain cancer.

UNC Lineberger’s Shawn Hingtgen, PhD, and his collaborators showed they could shrink tumors in laboratory models of medulloblastoma, and extend life. The study, published in PLOS ONE, is a necessary step toward developing clinical trials that would see if the approach works for children.

UNC Lineberger's Simon Khagi, MD, is director of the University of North Carolina Brain Tumor Program.

Simon Khagi, MD, aspired to be a cardiologist when he was starting his medical training, but a clinical rotation in oncology during his residency changed his focus. Now, he says he can’t imagine not being a neuro-oncologist and having the opportunity to care for his patients and conduct research into new therapies for brain cancer.

Engineered stem cells (in blue) suspended in a gel home in on a glioblastoma tumor (in yellow) in a test-tube experiment at UNC.

UNC Lineberger's Shawn Hingtgen, PhD, and colleagues, in laboratory studies, have converted human skin cells into stem cells that can hunt down and kill human brain cancer, an important step to moving the approach closer to a clinical trial.

Tag: Brain Cancer

News & Observer: Common lab molecule surprises researchers with potential cancer-fighting properties

SCI NC: Using genetics to root out cancer

Researchers find clues to drug resistance in medulloblastoma subtype

Researchers identify possible approach to block medulloblastoma growth

Charles M. Perou, PhD: From studying one gene, to studying thousands in breast cancer

Grateful patient works with lab team to find cancer therapies

KFSN-TV: Battling brain tumors with Optune

Stem cells show promise as drug delivery tool for childhood brain cancer

A few minutes with Simon Khagi, MD

Revolutionary approach for treating glioblastoma works with human cells